Harpoon_logo (002).jpg
Harpoon Therapeutics Expands Leadership Team
06 juil. 2022 07h30 HE | Harpoon Therapeutics
Appointments named for two key executive leadership positions in human resources and translational medicine SOUTH SAN FRANCISCO, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc....
22157.jpg
Global CAR T Cell Therapy Market Research 2022: Opportunity & Clinical Pipeline Insights to 2028 - Insight On More Than 600 CAR T Cell Therapies In Clinical Trials
16 juin 2022 04h33 HE | Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Outlook on the KRAS Inhibitors Global Market to 2028 - Key Drivers and Challenges
27 avr. 2022 05h28 HE | Research and Markets
Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The advancement in...
22157.jpg
Outlook on the CAR-T Cell Therapies Industry - In-depth Review of the Various Patents and Affiliated IP Documents
25 avr. 2022 05h58 HE | Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions,...
22157.jpg
Gamma Delta T Cell Therapy Represents One of the Most Promising T Cell Therapies in Clinical Development
21 avr. 2022 07h38 HE | Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Gamma Delta T Cell Cancer Therapy Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The...
Global $33+ Billion CAR-T Cell Therapy Markets, 2017-2021 & 2022-2027: Focus on Yescarta, Kymriah, Tecartus, Breyanzi, Abecma
05 avr. 2022 04h33 HE | Research and Markets
Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market, By Product Type, By Tumor Type, By Indication, By Treatment Type, By Targeted Antigen, By End User, By Region,...
Global Car T Cell Therapy Market (2021 to 2028) - Size, Share, Outlook, and Opportunity Analysis
14 févr. 2022 05h43 HE | Research and Markets
Dublin, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The "Car T Cell Therapy Market" report has been added to ResearchAndMarkets.com's offering. Chimeric antigen receptor (CAR) T-cell therapy is a type of...
22157.jpg
Global CAR T-cell Therapy Market (2021 to 2031) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts
18 janv. 2022 06h58 HE | Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to...
22157.jpg
Regulatory T-Cell Therapies Market, 2035
11 janv. 2022 04h58 HE | Research and Markets
Dublin, Jan. 11, 2022 (GLOBE NEWSWIRE) -- The "Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035" report has...
22157.jpg
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research & Developments, 2018-2020 & 2021-2026
17 déc. 2021 07h38 HE | Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy" report has been added to ResearchAndMarkets.com's...